Abstract
Background ‘Inhalants’ have been associated with poorer mental health in adolescence, but little is known of associations with specific types of inhalants. Aims We aimed to investigate associations of using volatile substances, nitrous oxide and alkyl nitrates with mental health problems in adolescence. Method We conducted a cross-sectional analysis using data from 13- to 14-year-old adolescents across England and Wales collected between September 2019 and March 2020. Multilevel logistic regression examined associations between lifetime use of volatile substances, nitrous oxide and alkyl nitrates with self-reported symptoms of probable depression, anxiety, conduct disorder and auditory hallucinations. Results Of the 6672 adolescents in the study, 5.1% reported use of nitrous oxide, 4.9% volatile solvents and 0.1% alkyl nitrates. After accounting for multiple testing, adolescents who had used volatile solvents were significantly more likely to report probable depressive (odds ratio = 4.59, 95% CI 3.58, 5.88), anxiety (odds ratio = 3.47, 95% CI 2.72, 4.43) or conduct disorder (odds ratio = 7.52, 95% CI 5.80, 9.76) and auditory hallucinations (odds ratio = 5.35, 95% CI 4.00, 7.17) than those who had not. Nitrous oxide use was significantly associated with probable depression and conduct disorder but not anxiety disorder or auditory hallucinations. Alkyl nitrate use was rare and not associated with mental health outcomes. Adjustment for use of other inhalants, tobacco and alcohol resulted in marked attenuation but socioeconomic disadvantage had little effect. Conclusion To our knowledge, this study provides the first general population evidence that volatile solvents and nitrous oxide are associated with probable mental health disorders in adolescence. These findings require replication, ideally with prospective designs.
Original language | English |
---|---|
Pages (from-to) | 10-15 |
Number of pages | 6 |
Journal | British Journal of Psychiatry |
Volume | 226 |
Issue number | 1 |
Early online date | 14 Oct 2024 |
DOIs | |
Publication status | Published - 1 Jan 2025 |
Bibliographical note
For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.Data Availability Statement
The data that support the findings of this study are openly available at http:doi.org/10.17035/d.2023.0244798057.Funding
This work was supported by the National Institute of Health Research (NIHR) Public Health Research programme (grant number NIHR PHR 17/97/02) and The Centre for Development, Evaluation, Complexity and Implementation in Public Health Improvement (DECIPHer), which is a UKCRC Public Health Research Centre of Excellence. This work was jointly funded by the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Medical Research Council, the Welsh Government and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration (MR/KO232331/1), and since April 2020 the Welsh Government, through Health and Care Research Wales. This work was also supported by the Medical Research Council (MC_UU_00022/1) and the Chief Scientist Office (SPHSU16).
Keywords
- alkyl nitrate
- inhalants
- mental health
- nitrous oxide
- Volatile substances
ASJC Scopus subject areas
- Psychiatry and Mental health